Prognostic biomarkers in stage IV non-small cell lung cancer (NSCLC): neutrophil to lymphocyte ratio (NLR), lymphocyte to monocyte ratio (LMR), platelet to lymphocyte ratio (PLR) and advanced lung cancer inflammation index (ALI)

Hiren Mandaliya(Lake Macquarie Private Hospital), Ina Nordman(Calvary Mater Newcastle Hospital), Christopher Oldmeadow(Hunter Medical Research Institute), Mark Jones(Hunter Medical Research Institute)
Translational Lung Cancer Research
December 1, 2019
Cited by 392


Related Papers